Human Genome Epidemiology Literature Finder
Filtered By: |
Previous |
Records 1 - 7 (of 7 Records) |
Query Trace: Li-Fraumeni Syndrome and CHEK2[original query] |
---|
CHEK2 1100delC is not a risk factor for male breast cancer population. International journal of cancer. Journal international du cancer 2004 Jan 108 (3): 475-6. Syrjäkoski Kirsi, Kuukasjärvi Tuula, Auvinen Anssi, Kallioniemi Olli |
Contribution of the CHEK2 1100delC variant to risk of multiple colorectal adenoma and carcinoma. Cancer letters 2003 Oct 200 (2): 149-52. Lipton Lara, Fleischmann Christina, Sieber Oliver M, Thomas Huw J W, Hodgson Shirley V, Tomlinson Ian P M, Houlston Richard |
The contribution of CHEK2 to the TP53-negative Li-Fraumeni phenotype. Hereditary cancer in clinical practice 2009 7 (1): 4. Ruijs Marielle W G, Broeks Annegien, Menko Fred H, Ausems Margreet G E M, Wagner Anja, Oldenburg Rogier, Meijers-Heijboer Hanne, van't Veer Laura J, Verhoef Sen |
Breast cancer patients suggestive of Li-Fraumeni syndrome: mutational spectrum, candidate genes, and unexplained heredity. Breast cancer research : BCR 2018 Aug 20 (1): 87. Penkert Judith, Schmidt Gunnar, Hofmann Winfried, Schubert Stephanie, Schieck Maximilian, Auber Bernd, Ripperger Tim, Hackmann Karl, Sturm Marc, Prokisch Holger, Hille-Betz Ursula, Mark Dorothea, Illig Thomas, Schlegelberger Brigitte, Steinemann Dor |
Mutation screening of TP53, CHEK2 and BRCA genes in patients at high risk for hereditary breast and ovarian cancer (HBOC) in Brazil. Breast cancer (Tokyo, Japan) 2018 12 26 (3): 397-405. Cipriano Nilson Moreira, de Brito Amanda Marques, de Oliveira Eneida Santos, de Faria Fabiana Castro, Lemos Sara, Rodrigues Angélica Nogueira, de Oliveira Lopes Débora, Dos Santos Luciana La |
Pancreatic Cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation. Genes 2022 2 13 (2): . Vietri Maria Teresa, D'Elia Giovanna, Caliendo Gemma, Albanese Luisa, Signoriello Giuseppe, Napoli Claudio, Molinari Anna Mar |
The Impact of Li Fraumeni and Germline Retinoblastoma Mutations on Leiomyosarcoma Initiation, Outcomes and Genetic Testing Recommendations. Clinical cancer research : an official journal of the American Association for Cancer Research 2024 8 . Josephine K Dermawan, David H Abramson, Sarah Chiang, Martee L Hensley, William D Tap, Sujana Movva, Robert G Maki, Diana Mandelker, Cristina R Antones |
- Page last reviewed:Feb 1, 2024
- Content source: